Last reviewed · How we verify
NCT06014645
Effectiveness of Home Programs After Lumbar Spinal Decompression Surgery
NA trial testing Rehabilitation in Lumbar Spine Disease in 22 participants. Completed in 15 April 2024.
10 April 2024
Quick facts
| Lead sponsor | Muğla Sıtkı Koçman University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 14 June 2023 |
| Primary completion | 10 April 2024 |
| Estimated completion | 15 April 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Rehabilitation
- Control
Conditions studied
- Lumbar Spine Disease — all drugs for Lumbar Spine Disease →
Sponsor
Muğla Sıtkı Koçman University
Who can join
Adults 18 to 65, any sex, with Lumbar Spine Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will be conducted with volunteer patients who are followed up by Bursa Çekirge State Hospital Cekirge State Hospital Neurosurgery outpatient clinic and who have undergone lumbar decompression surgery and who meet the study criteria. The cases will be divided into 2 groups by randomization software. The control group will receive post-operative exercise training and will be encouraged to move. The study group will receive a core stabilization program in addition to education via telerehabilitation. The first evaluation will be performed 2 months post-operatively and the second evaluation will be performed 2 months after treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06014645
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Rehabilitation
Trials testing the same drug.
- NCT07320222 — CARE-Melanoma Trial · Phase 1 · not yet recruiting
- NCT06926699 — MPFL Reconstruction Versus Rehabilitation · NA · not yet recruiting
- NCT06818201 — Effects of tDCS on Motor Cortex During ACL Recovery · NA · recruiting
- NCT07105657 — The Outcome of Three Weeks Rehabilitation in Patients With a Total Hip or Knee Replacement Experiencing Persistent Physi · recruiting
- NCT06939309 — Efficacy of Acupuncture for Shoulder Pain Based on Remote Point Selection According to the Meridians · NA · not yet recruiting
Other Muğla Sıtkı Koçman University trials
Trials by the same sponsor.
- NCT05046834 — Effect of Cold Application on Patient's Pain and Vital Signs During Chest Tube Removal. · NA · withdrawn
- NCT07323160 — Determining the Effect of Education Given to Patients Undergoing Outpatient Anal Fistula Surgery · NA · not yet recruiting
- NCT07308730 — Pain Diary Use After Laparoscopic Cholecystectomy · NA · recruiting
- NCT06704399 — Psychoeducation Based on Acceptance and Commitment Therapy · NA · not yet recruiting
- NCT07183956 — Comparison of the Silverman-Andersen Score and the Downes Score · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06014645 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muğla Sıtkı Koçman University
- Last refreshed: 7 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06014645.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing